Triglyceride‐Glucose Index Association With Severity of Coronary Artery Disease
Endocrinology, Diabetes & Metabolism · 2025
DOI: 10.1002/edm2.70025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2025. Verfasst von Sara Saffar Soflaei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Coronary Artery Disease, Triglycerides, Blood Glucose. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Background
Despite previous studies, the relationship between the triglyceride‐glucose (TyG) index and coronary artery disease (CAD) is still undetermined. So we aimed to investigate the association between the TyG index and CAD.
Method
A total of 2346 subjects were enrolled in the study and were categorised into 5: those with no CAD, angiogram negative (Ang−) patients, those with single‐vessel disease (SVD), or two‐vessel disease (2VD) or three‐vessel disease (3VD). Demographic characteristics, disease history and biochemical investigations were recorded. TyG index was calculated as Ln [fasting TG (mg/dL) × fasting glucose (mg/dL)/2].
Results
Adjusted regression models demonstrated that the odds of 3VD (OR, 5.847; 95% CI, 4.391–7.784), 2VD (OR, 4.943; 95% CI, 3.597–6.791), SVD (OR, 4.722; 95% CI 3.448–6.647) and a negative coronary angiogram (OR, 3.137; 95% CI, 2.431–4.049), increased significantly per each unit elevation of the TyG index, compared to the healthy participants. Also, the odds for being 3VD (1.864, 95%CI 1.402–2.477, p ‐value < 0.001), 2VD (1.575, 95%CI 1.143–2.171, p ‐value = 0.005) and SVD (1.505, 95%CI 1.097–2.065, p ‐value = 0.011) were increased significantly by one‐unit elevation of TyG index, compared to Ang− group.
Conclusion
Our study demonstrates a significant association between elevated TyG index and the presence and severity of CAD. Higher TyG index values were consistently linked to an increased likelihood of multivessel CAD, especially in diabetic patients. These findings suggest that the TyG index could serve as a valuable marker for assessing CAD risk and stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.
- School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
- Faculty of Medicine, Islamic Azad University Medical Branch of Mashhad, Mashhad, Iran.
- Department of Health Education and Health, Faculty of Health Promotion, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Majid Ghayour-Mobarhan
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Saffar Soflaei, S., Salehi-Sangani, P., Fallahi, Z., Imanparast, F., Marousi, M., Tajfard, M., Ferns, G. A., Moohebati, M., & Ghayour-Mobarhan, M. (2025). Triglyceride‐Glucose Index Association With Severity of Coronary Artery Disease. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70025
Vancouver
Saffar Soflaei S, Salehi-Sangani P, Fallahi Z, Imanparast F, Marousi M, Tajfard M, et al. Triglyceride‐Glucose Index Association With Severity of Coronary Artery Disease. Endocrinology, Diabetes & Metabolism. 2025. doi:10.1002/edm2.70025
BibTeX
@article{SaffarSoflaei2025,
author = {Saffar Soflaei, Sara and Salehi-Sangani, Pooria and Fallahi, Zahra and Imanparast, Fatemeh and Marousi, Mahdieh and Tajfard, Mohammad and Ferns, Gordon A and Moohebati, Mohsen and Ghayour-Mobarhan, Majid},
title = {Triglyceride‐Glucose Index Association With Severity of Coronary Artery Disease},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2025},
doi = {10.1002/edm2.70025}
}
EUVIMED